KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
HLA-A |
HLA class I histocompatibility antigen, A-68 alpha chain |
[1] |
-0.80[2] |
-0.62[3] |
-6.43[4] |
-0.35[5] |
-1.16[6] |
-1.91[7] |
2 |
HLA-C |
HLA class I histocompatibility antigen, Cw-17 alpha chain |
[8] |
-1.66[9] |
-2.39[10] |
-6.07[11] |
-1.12[12] |
-0.87[13] |
-1.52[14] |
3 |
HLA-B |
HLA class I histocompatibility antigen, B-73 alpha chain |
[15] |
-2.63[16] |
-4.02[17] |
-8.19[18] |
0.31[19] |
-0.49[20] |
-1.17[21] |
4 |
HLA-E |
HLA class I histocompatibility antigen, alpha chain E |
[22] |
-1.46[23] |
-1.67[24] |
-1.93[25] |
-0.20[26] |
-1.36[27] |
0.35[28] |
5 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
[29] |
-0.02[30] |
-0.42[31] |
0.47[32] |
-0.08[33] |
0.11[34] |
-0.80[35] |
6 |
IFNGR1 |
Interferon gamma receptor 1 |
[36] |
1.15[37] |
-0.04[38] |
-1.31[39] |
-0.47[40] |
-0.51[41] |
-0.15[42] |
7 |
MAP2K1 |
Dual specificity mitogen-activated protein kinase kinase 1 |
[43] |
-0.56[44] |
-0.96[45] |
-0.19[46] |
-0.63[47] |
0.08[48] |
-1.02[49] |
8 |
MAP2K2 |
Dual specificity mitogen-activated protein kinase kinase 2 |
[50] |
0.43[51] |
0.03[52] |
1.08[53] |
-0.93[54] |
-0.24[55] |
-1.53[56] |
9 |
PTPN11 |
Tyrosine-protein phosphatase non-receptor type 11 |
[57] |
0.82[58] |
1.18[59] |
1.31[60] |
0.80[61] |
1.64[62] |
1.43[63] |
10 |
GRB2 |
Growth factor receptor-bound protein 2 |
[64] |
1.57[65] |
1.34[66] |
1.64[67] |
0.46[68] |
0.58[69] |
0.47[70] |
11 |
TNFSF10 |
Tumor necrosis factor ligand superfamily member 10 |
[71] |
-4.10[72] |
-2.57[73] |
0.24[74] |
-2.56[75] |
-5.60[76] |
-1.22[77] |
12 |
SHC1 |
SHC-transforming protein 1 |
[78] |
1.54[79] |
1.69[80] |
1.94[81] |
2.56[82] |
2.25[83] |
0.95[84] |
13 |
IFNGR2 |
Interferon gamma receptor 2 |
[85] |
0.34[86] |
0.83[87] |
-1.01[88] |
-1.46[89] |
0.04[90] |
-0.42[91] |
14 |
RAF1 |
RAF proto-oncogene serine/threonine-protein kinase |
[92] |
0.31[93] |
0.65[94] |
2.09[95] |
-0.28[96] |
0.79[97] |
1.26[98] |
15 |
TNFRSF10B |
Tumor necrosis factor receptor superfamily member 10B |
[99] |
2.36[100] |
2.17[101] |
2.15[102] |
-0.42[103] |
1.40[104] |
0.20[105] |
16 |
NRAS |
GTPase NRas |
[106] |
1.00[107] |
1.36[108] |
1.96[109] |
0.91[110] |
0.68[111] |
-0.08[112] |
17 |
ICAM1 |
Intercellular adhesion molecule 1 |
[113] |
2.27[114] |
1.57[115] |
2.17[116] |
0.10[117] |
2.48[118] |
-0.24[119] |
18 |
PPP3R1 |
Calcineurin subunit B type 1 |
[120] |
0.56[121] |
0.67[122] |
0.77[123] |
0.61[124] |
0.58[125] |
-0.98[126] |
19 |
IFNAR2 |
Interferon alpha/beta receptor 2 |
[127] |
-0.84[128] |
-1.25[129] |
-0.39[130] |
-1.48[131] |
-1.28[132] |
-0.61[133] |
20 |
CASP3 |
Caspase-3 |
[134] |
0.51[135] |
1.11[136] |
-1.25[137] |
-0.99[138] |
0.21[139] |
-0.64[140] |
21 |
ARAF |
Serine/threonine-protein kinase A-Raf |
[141] |
-0.08[142] |
-0.46[143] |
-0.01[144] |
-0.19[145] |
0.05[146] |
1.04[147] |
22 |
BID |
BH3-interacting domain death agonist |
[148] |
0.10[149] |
0.14[150] |
-0.06[151] |
-0.38[152] |
-0.71[153] |
0.34[154] |
23 |
TYROBP |
TYRO protein tyrosine kinase-binding protein |
[155] |
-9.58[156] |
[157] |
[158] |
-9.15[159] |
[160] |
-1.49[161] |
24 |
MICA |
MHC class I polypeptide-related sequence A |
[162] |
-0.78[163] |
-0.09[164] |
-3.89[165] |
-0.74[166] |
-0.50[167] |
-2.72[168] |
25 |
HRAS |
GTPase HRas |
[169] |
-0.64[170] |
-1.41[171] |
-2.02[172] |
-1.04[173] |
-1.05[174] |
-2.49[175] |
26 |
FCER1G |
High affinity immunoglobulin epsilon receptor subunit gamma |
[176] |
-4.70[177] |
-3.88[178] |
-6.67[179] |
-8.55[180] |
-6.32[181] |
-0.80[182] |
27 |
FAS |
Tumor necrosis factor receptor superfamily member 6 |
[183] |
-1.23[184] |
-0.52[185] |
-8.35[186] |
-1.84[187] |
-1.11[188] |
-1.56[189] |
28 |
MAPK1 |
Mitogen-activated protein kinase 1 |
[190] |
2.08[191] |
2.15[192] |
2.16[193] |
1.76[194] |
1.61[195] |
1.94[196] |
29 |
SHC2 |
SHC-transforming protein 2 |
[197] |
-1.01[198] |
-0.73[199] |
-1.39[200] |
-4.76[201] |
-4.18[202] |
-0.21[203] |
30 |
KRAS |
GTPase KRas |
[204] |
-0.14[205] |
-0.23[206] |
1.55[207] |
0.71[208] |
0.58[209] |
0.84[210] |
31 |
VAV2 |
Guanine nucleotide exchange factor VAV2 |
[211] |
1.67[212] |
1.85[213] |
1.53[214] |
-0.63[215] |
0.00[216] |
0.68[217] |
32 |
TNFRSF10A |
Tumor necrosis factor receptor superfamily member 10A |
[218] |
-1.07[219] |
-1.60[220] |
-1.40[221] |
-3.11[222] |
-3.16[223] |
-1.54[224] |
33 |
IFNAR1 |
Interferon alpha/beta receptor 1 |
[225] |
0.43[226] |
0.84[227] |
0.72[228] |
0.90[229] |
1.09[230] |
2.60[231] |
34 |
PIK3R1 |
Phosphatidylinositol 3-kinase regulatory subunit alpha |
[232] |
-0.10[233] |
-0.05[234] |
1.22[235] |
1.98[236] |
1.68[237] |
3.17[238] |
35 |
SOS1 |
Son of sevenless homolog 1 |
[239] |
0.27[240] |
1.73[241] |
1.42[242] |
0.75[243] |
0.19[244] |
0.71[245] |
36 |
FCGR3A |
Low affinity immunoglobulin gamma Fc region receptor III-A |
[246] |
[247] |
[248] |
[249] |
-10.08[250] |
[251] |
1.05[252] |
37 |
TNFRSF10D |
Tumor necrosis factor receptor superfamily member 10D |
[253] |
2.12[254] |
2.09[255] |
2.83[256] |
0.33[257] |
-0.31[258] |
0.19[259] |
38 |
PTPN6 |
Tyrosine-protein phosphatase non-receptor type 6 |
[260] |
-0.09[261] |
0.03[262] |
0.79[263] |
-7.23[264] |
-2.01[265] |
-0.01[266] |
39 |
PIK3R2 |
Phosphatidylinositol 3-kinase regulatory subunit beta |
[267] |
2.25[268] |
2.40[269] |
3.19[270] |
0.62[271] |
1.38[272] |
-0.12[273] |
40 |
PPP3CB |
Serine/threonine-protein phosphatase
2B catalytic subunit beta isoform |
0.86[274] |
1.58[275] |
1.27[276] |
0.66[277] |
0.62[278] |
0.02[279] |
41 |
NFATC3 |
Nuclear factor of activated T-cells, cytoplasmic 3 |
[280] |
1.84[281] |
2.55[282] |
2.62[283] |
0.77[284] |
1.36[285] |
2.57[286] |
42 |
MAPK3 |
Mitogen-activated protein kinase 3 |
[287] |
2.22[288] |
2.20[289] |
2.42[290] |
0.33[291] |
0.56[292] |
-0.87[293] |
43 |
HLA-G |
HLA class I histocompatibility antigen, alpha chain G |
[294] |
-2.65[295] |
-3.72[296] |
-8.23[297] |
-1.42[298] |
-7.33[299] |
-3.63[300] |
44 |
PPP3CC |
Serine/threonine-protein phosphatase
2B catalytic subunit gamma isoform |
-0.33[301] |
-0.26[302] |
-0.48[303] |
-1.18[304] |
-0.06[305] |
0.23[306] |
45 |
RAC2 |
Ras-related C3 botulinum toxin substrate 2 |
[307] |
-1.34[308] |
-7.40[309] |
-7.83[310] |
-1.48[311] |
2.53[312] |
-1.06[313] |
46 |
PLCG1 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase gamma-1 |
3.86[314] |
3.41[315] |
2.92[316] |
2.73[317] |
2.43[318] |
0.51[319] |
47 |
ITGB2 |
Integrin beta-2 |
[320] |
1.67[321] |
2.98[322] |
-5.12[323] |
-5.28[324] |
-7.06[325] |
1.48[326] |
48 |
PPP3CA |
Serine/threonine-protein phosphatase
2B catalytic subunit alpha isoform |
1.10[327] |
0.79[328] |
0.78[329] |
1.85[330] |
1.80[331] |
1.97[332] |
49 |
PIK3CB |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit beta isoform |
1.58[333] |
2.02[334] |
2.36[335] |
0.96[336] |
1.32[337] |
1.32[338] |
50 |
ULBP3 |
UL16-binding protein 3 |
[339] |
-5.56[340] |
[341] |
-3.40[342] |
-9.26[343] |
-3.35[344] |
-4.97[345] |
51 |
RAC3 |
Ras-related C3 botulinum toxin substrate 3 |
[346] |
0.00[347] |
2.99[348] |
2.01[349] |
0.02[350] |
-1.26[351] |
-3.31[352] |
52 |
SH3BP2 |
SH3 domain-binding protein 2 |
[353] |
1.78[354] |
2.28[355] |
1.90[356] |
3.15[357] |
1.76[358] |
3.10[359] |
53 |
SOS2 |
Son of sevenless homolog 2 |
[360] |
0.35[361] |
1.40[362] |
0.81[363] |
1.60[364] |
1.67[365] |
2.01[366] |
54 |
PRKCA |
Protein kinase C alpha type |
[367] |
3.21[368] |
3.18[369] |
3.72[370] |
2.06[371] |
2.63[372] |
2.09[373] |
55 |
PAK1 |
Serine/threonine-protein kinase PAK 1 |
[374] |
0.36[375] |
-0.47[376] |
2.12[377] |
-1.95[378] |
2.04[379] |
0.44[380] |
56 |
FYN |
Tyrosine-protein kinase Fyn |
[381] |
1.31[382] |
-7.36[383] |
1.39[384] |
1.38[385] |
3.11[386] |
1.14[387] |
57 |
HCST |
Hematopoietic cell signal transducer |
[388] |
-3.41[389] |
-4.21[390] |
-7.65[391] |
-4.90[392] |
-5.52[393] |
-1.58[394] |
58 |
PIK3CA |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit alpha isoform |
-0.01[395] |
1.56[396] |
1.93[397] |
1.04[398] |
1.45[399] |
2.08[400] |
59 |
PIK3CD |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit delta isoform |
2.26[401] |
3.28[402] |
-0.36[403] |
0.19[404] |
1.16[405] |
0.47[406] |
60 |
CD48 |
CD48 antigen |
[407] |
[408] |
[409] |
[410] |
[411] |
[412] |
-1.11[413] |
61 |
PTK2B |
Protein-tyrosine kinase 2-beta |
[414] |
-0.43[415] |
0.85[416] |
2.00[417] |
-1.87[418] |
0.96[419] |
1.94[420] |
62 |
RAET1L |
UL16-binding protein 6 |
[421] |
-9.94[422] |
[423] |
[424] |
[425] |
-8.61[426] |
[427] |
63 |
MICB |
MHC class I polypeptide-related sequence B |
[428] |
2.66[429] |
2.91[430] |
3.49[431] |
1.45[432] |
2.68[433] |
-1.60[434] |
64 |
ICAM2 |
Intercellular adhesion molecule 2 |
[435] |
0.56[436] |
0.19[437] |
-2.21[438] |
-4.98[439] |
-9.58[440] |
-0.09[441] |
65 |
BRAF |
Serine/threonine-protein kinase B-raf |
[442] |
0.62[443] |
0.28[444] |
2.49[445] |
0.65[446] |
0.55[447] |
2.02[448] |
66 |
KLRD1 |
Natural killer cells antigen CD94 |
[449] |
-2.61[450] |
-1.61[451] |
-1.27[452] |
-1.65[453] |
-1.70[454] |
0.28[455] |
67 |
PLCG2 |
1-phosphatidylinositol
4,5-bisphosphate phosphodiesterase gamma-2 |
-0.91[456] |
-6.72[457] |
0.90[458] |
-2.83[459] |
-1.47[460] |
2.88[461] |
68 |
NFAT5 |
Nuclear factor of activated T-cells 5 |
[462] |
3.96[463] |
4.67[464] |
4.86[465] |
3.80[466] |
3.63[467] |
4.80[468] |
69 |
ITGAL |
Integrin alpha-L |
[469] |
-0.25[470] |
1.54[471] |
3.39[472] |
-4.38[473] |
-4.08[474] |
2.31[475] |
70 |
ULBP2 |
UL16-binding protein 2 |
[476] |
-6.43[477] |
-6.89[478] |
0.74[479] |
0.99[480] |
1.58[481] |
-4.08[482] |
71 |
LCP2 |
Lymphocyte cytosolic protein 2 |
[483] |
[484] |
[485] |
[486] |
-3.80[487] |
[488] |
1.31[489] |
72 |
RAET1E |
Retinoic acid early transcript 1E |
[490] |
-3.89[491] |
-3.26[492] |
-3.30[493] |
-1.83[494] |
-0.71[495] |
-2.70[496] |
73 |
LAT |
Linker for activation of T-cells family member 1 |
[497] |
-1.08[498] |
0.39[499] |
-1.02[500] |
-1.45[501] |
-0.67[502] |
-0.25[503] |
74 |
VAV3 |
Guanine nucleotide exchange factor VAV3 |
[504] |
2.18[505] |
0.40[506] |
2.75[507] |
3.59[508] |
-2.18[509] |
1.52[510] |
75 |
PRF1 |
Perforin-1 |
[511] |
4.33[512] |
-2.96[513] |
-6.48[514] |
-7.80[515] |
-6.24[516] |
1.62[517] |
76 |
TNFRSF10C |
Tumor necrosis factor receptor superfamily member 10C |
[518] |
-1.65[519] |
-0.81[520] |
-2.21[521] |
-3.41[522] |
-3.84[523] |
0.57[524] |
77 |
VAV1 |
Proto-oncogene vav |
[525] |
-8.13[526] |
-3.37[527] |
-4.90[528] |
-6.18[529] |
-7.23[530] |
1.35[531] |
78 |
PIK3R3 |
Phosphatidylinositol 3-kinase regulatory subunit gamma |
[532] |
2.09[533] |
2.03[534] |
3.06[535] |
3.08[536] |
2.30[537] |
2.84[538] |
79 |
NFATC1 |
Nuclear factor of activated T-cells, cytoplasmic 1 |
[539] |
-1.58[540] |
-4.16[541] |
2.62[542] |
-6.07[543] |
2.55[544] |
0.89[545] |
80 |
ULBP1 |
UL16-binding protein 1 |
[546] |
-0.52[547] |
[548] |
1.48[549] |
-0.67[550] |
0.96[551] |
-4.70[552] |
81 |
PIK3R5 |
Phosphoinositide 3-kinase regulatory subunit 5 |
[553] |
-6.80[554] |
[555] |
-2.05[556] |
-4.01[557] |
-3.47[558] |
2.51[559] |
82 |
CD247 |
T-cell surface glycoprotein CD3 zeta chain |
[560] |
-4.50[561] |
-5.24[562] |
-6.56[563] |
-3.60[564] |
-4.78[565] |
0.15[566] |
83 |
KLRK1 |
NKG2-D type II integral membrane protein |
[567] |
[568] |
[569] |
[570] |
-6.40[571] |
[572] |
-3.68[573] |
84 |
NFATC2 |
Nuclear factor of activated T-cells, cytoplasmic 2 |
[574] |
2.96[575] |
4.15[576] |
3.74[577] |
0.09[578] |
1.25[579] |
3.45[580] |
85 |
LCK |
Tyrosine-protein kinase Lck |
[581] |
3.15[582] |
3.16[583] |
-6.65[584] |
-5.17[585] |
-5.17[586] |
1.40[587] |
86 |
GZMB |
Granzyme B |
[588] |
-4.25[589] |
[590] |
[591] |
[592] |
[593] |
-0.54[594] |
87 |
SYK |
Tyrosine-protein kinase SYK |
[595] |
-7.79[596] |
-1.99[597] |
-4.83[598] |
0.01[599] |
-3.30[600] |
3.53[601] |
88 |
PRKCB |
Protein kinase C beta type |
[602] |
-6.44[603] |
-5.31[604] |
[605] |
2.39[606] |
-2.71[607] |
3.70[608] |
89 |
CD244 |
Natural killer cell receptor 2B4 |
[609] |
[610] |
[611] |
-2.16[612] |
[613] |
-1.52[614] |
1.96[615] |
90 |
ZAP70 |
Tyrosine-protein kinase ZAP-70 |
[616] |
1.37[617] |
1.52[618] |
-4.52[619] |
-5.63[620] |
-4.08[621] |
2.33[622] |
91 |
IFNG |
Interferon gamma |
[623] |
[624] |
[625] |
[626] |
-0.78[627] |
[628] |
-2.13[629] |
92 |
NCR3 |
Natural cytotoxicity triggering receptor 3 |
[630] |
-4.64[631] |
[632] |
[633] |
-5.43[634] |
-5.90[635] |
-1.25[636] |
93 |
SH2D1A |
SH2 domain-containing protein 1A |
[637] |
[638] |
[639] |
-6.30[640] |
[641] |
[642] |
1.03[643] |
94 |
CHP2 |
Calcineurin B homologous protein 2 |
[644] |
-0.17[645] |
-0.68[646] |
-1.35[647] |
-1.68[648] |
-1.88[649] |
-1.73[650] |
95 |
TNF |
Tumor necrosis factor |
[651] |
1.47[652] |
-0.73[653] |
-5.15[654] |
-2.31[655] |
-5.33[656] |
-1.72[657] |
96 |
RAET1G |
UL-16 binding protein 5 |
[658] |
-3.20[659] |
[660] |
-3.17[661] |
1.06[662] |
1.23[663] |
-1.97[664] |
97 |
SH2D1B |
SH2 domain-containing protein 1B |
[665] |
-5.52[666] |
[667] |
-3.13[668] |
-2.93[669] |
-4.20[670] |
1.48[671] |
98 |
FASLG |
Tumor necrosis factor ligand superfamily member 6 |
[672] |
-3.44[673] |
-1.64[674] |
-5.43[675] |
[676] |
[677] |
0.75[678] |
99 |
PIK3CG |
Phosphatidylinositol
4,5-bisphosphate 3-kinase catalytic subunit gamma isoform |
[679] |
[680] |
[681] |
1.25[682] |
-3.43[683] |
4.27[684] |
100 |
SHC4 |
SHC-transforming protein 4 |
[685] |
-1.89[686] |
[687] |
-1.22[688] |
2.44[689] |
3.02[690] |
-0.52[691] |
101 |
KLRC3 |
NKG2-E type II integral membrane protein |
[692] |
2.65[693] |
1.69[694] |
-2.05[695] |
0.17[696] |
-3.32[697] |
1.54[698] |
102 |
SHC3 |
SHC-transforming protein 3 |
[699] |
2.48[700] |
4.79[701] |
-2.52[702] |
3.37[703] |
7.48[704] |
1.99[705] |
103 |
PRKCG |
Protein kinase C gamma type |
[706] |
-0.45[707] |
0.15[708] |
-2.04[709] |
-1.15[710] |
-1.04[711] |
[712] |
104 |
CSF2 |
Granulocyte-macrophage colony-stimulating factor |
[713] |
0.83[714] |
-3.18[715] |
-2.37[716] |
-1.81[717] |
6.30[718] |
-1.31[719] |
105 |
NCR1 |
Natural cytotoxicity triggering receptor 1 |
[720] |
[721] |
[722] |
[723] |
[724] |
[725] |
2.27[726] |
106 |
KIR2DS4 |
Killer cell immunoglobulin-like receptor 2DS4 |
[727] |
[728] |
[729] |
[730] |
[731] |
[732] |
-1.08[733] |
107 |
FCGR3B |
Low affinity immunoglobulin gamma Fc region receptor III-B |
[734] |
[735] |
[736] |
[737] |
[738] |
-2.02[739] |
4.83[740] |
108 |
NFATC4 |
Nuclear factor of activated T-cells, cytoplasmic 4 |
[741] |
3.03[742] |
0.23[743] |
3.40[744] |
2.65[745] |
8.69[746] |
5.39[747] |
109 |
KIR3DL2 |
Killer cell immunoglobulin-like receptor 3DL2 |
[748] |
[749] |
[750] |
[751] |
[752] |
[753] |
-0.38[754] |
110 |
KLRC1 |
NKG2-A/NKG2-B type II integral membrane protein |
[755] |
2.59[756] |
0.99[757] |
[758] |
-0.06[759] |
0.98[760] |
4.09[761] |
111 |
KIR2DL1 |
Killer cell immunoglobulin-like receptor 2DL1 |
[762] |
[763] |
[764] |
[765] |
[766] |
-1.14[767] |
2.24[768] |
112 |
KIR2DL3 |
Killer cell immunoglobulin-like receptor 2DL3 |
[769] |
[770] |
[771] |
[772] |
[773] |
[774] |
1.58[775] |
113 |
IFNA21 |
Interferon alpha-21 |
[776] |
[777] |
[778] |
[779] |
[780] |
[781] |
[782] |
114 |
KIR2DL2 |
Killer cell immunoglobulin-like receptor 2DL2 |
[783] |
[784] |
[785] |
[786] |
[787] |
[788] |
[789] |
115 |
IFNA6 |
Interferon alpha-6 |
[790] |
[791] |
[792] |
[793] |
[794] |
[795] |
[796] |
116 |
PPP3R2 |
Calcineurin subunit B type 2 |
[797] |
[798] |
[799] |
[800] |
[801] |
[802] |
[803] |
117 |
KIR2DS1 |
Killer cell immunoglobulin-like receptor 2DS1 |
[804] |
[805] |
[806] |
[807] |
[808] |
[809] |
[810] |
118 |
KIR2DS5 |
Killer cell immunoglobulin-like receptor 2DS5 |
[811] |
[812] |
[813] |
[814] |
[815] |
[816] |
[817] |
119 |
KIR2DL4 |
Killer cell immunoglobulin-like receptor 2DL4 |
[818] |
[819] |
[820] |
[821] |
[822] |
[823] |
[824] |
120 |
IFNA7 |
Interferon alpha-7 |
[825] |
[826] |
[827] |
[828] |
[829] |
[830] |
[831] |
121 |
NCR2 |
Natural cytotoxicity triggering receptor 2 |
[832] |
[833] |
[834] |
[835] |
[836] |
[837] |
[838] |
122 |
IFNA4 |
Interferon alpha-4 |
[839] |
[840] |
[841] |
[842] |
[843] |
[844] |
[845] |
123 |
IFNA1 |
Interferon alpha-1/13 |
[846] |
[847] |
[848] |
[849] |
[850] |
[851] |
[852] |
124 |
KLRC2 |
NKG2-C type II integral membrane protein |
[853] |
[854] |
[855] |
[856] |
[857] |
[858] |
[859] |
125 |
IFNA13 |
|
[860] |
[861] |
[862] |
[863] |
[864] |
[865] |
[866] |
126 |
CHP1 |
Calcineurin B homologous protein 1 |
[867] |
[868] |
[869] |
[870] |
[871] |
[872] |
[873] |
127 |
IFNA2 |
Interferon alpha-2 |
[874] |
[875] |
[876] |
[877] |
[878] |
[879] |
[880] |
128 |
IFNA17 |
Interferon alpha-17 |
[881] |
[882] |
[883] |
[884] |
[885] |
[886] |
[887] |
129 |
IFNA8 |
Interferon alpha-8 |
[888] |
[889] |
[890] |
[891] |
[892] |
[893] |
[894] |
130 |
IFNA10 |
Interferon alpha-10 |
[895] |
[896] |
[897] |
[898] |
[899] |
[900] |
[901] |
131 |
IFNB1 |
Interferon beta |
[902] |
[903] |
[904] |
[905] |
[906] |
[907] |
[908] |
132 |
IFNA14 |
Interferon alpha-14 |
[909] |
[910] |
[911] |
[912] |
[913] |
[914] |
[915] |
133 |
KIR2DL5A |
Killer cell immunoglobulin-like receptor 2DL5A |
[916] |
[917] |
[918] |
[919] |
[920] |
[921] |
[922] |
134 |
IFNA5 |
Interferon alpha-5 |
[923] |
[924] |
[925] |
[926] |
[927] |
[928] |
[929] |
135 |
KIR3DL1 |
Killer cell immunoglobulin-like receptor 3DL1 |
[930] |
[931] |
[932] |
[933] |
[934] |
[935] |
[936] |
136 |
KIR2DS3 |
Killer cell immunoglobulin-like receptor 2DS3 |
[937] |
[938] |
[939] |
[940] |
[941] |
[942] |
[943] |
137 |
IFNA16 |
Interferon alpha-16 |
[944] |
[945] |
[946] |
[947] |
[948] |
[949] |
[950] |
|
|
|
|
|
|
|
|
|
|